Journals / Turkish Journal of Hematology / 2012 / Cilt: 29 - Sayı: 4

Co-existence of hereditary pyrimidine 5’-nucleotidase deficiency and heterozygous α-thalassemia: A case presentation

Kalıtsal pirimidin 5’- nükleotidaz eksikliği ve alfa talasemi taşıyıcı birlikteliği: Olgu sunumu

Pages
433–435
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

THEODORİDOU, S., MANDALA, E., LEUKOU, E., KARAKASİDOU, O., ALETRA, B., SEVASTİDOU, A., ALEMAYEHOU, M., VOSKARİDOU, E., TEGOS, K., AGAPİDOU, A. (2022). Co-existence of hereditary pyrimidine 5’-nucleotidase deficiency and heterozygous α-thalassemia: A case presentation. Turkish Journal of Hematology, Cilt: 29 - Sayı: 4, 433–435. https://ajindex.com/articles/606967

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Evdokia Mandala, Study of Pyrimidine 5- Nucleotide(P5N) Activity In Hereditary Hemoglobinopathies. Doctorate- Thesis, Thessaloniki 1997
  2. Zerez CR, Lachant NA, Lent KM, Tanaka KR. Decreased pyrimidine nucleoside monophosphate kinase activity in sickle erythrocytes. Blood 1992; 80:512-516
  3. David O, Sacchetti L, Vota MG, Comino L, Perugini L, Pescarmona GP. Pyrimidine 5’-nucleotidase and oxidative damage in red blood cells transfused to beta-thalassemic children. Haematologica 1990; 75:313-318
  4. Dell’Edera D, Malvasi A, Tinelli A, Mazzone E, Leo M, Monti V, Epifania AA. Importance of the molecular diagnosis in the screening of alpha-thalassemia. Recenti Prog Med 2011; 102(7-8):302-306. doi: 10.1701/913.10050. Italian.